The three types of conjugates (i.e., QD800-RGD, QD820-anti-CEACAM1, and QD840-anti-EGFR) were simultaneously detected in vivo, especially showed great potential to be used for tumor targeting agents with specific delineation of tumor region (Fig. 3D). The gene discussed is CEACAM1; the disease is neoplasm.